Solace Therapeutics, Inc. is a biotechnology company based in Framingham, MA, specializing in the development of innovative medical solutions aimed at improving patient outcomes. The company focuses on advanced therapeutic technologies, particularly in the fields of women's health and urology. By leveraging cutting-edge research and development, Solace Therapeutics aims to address unmet medical needs through its proprietary products and therapies, enhancing the quality of life for patients across various demographics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

10 Patents

#25 in Framingham, MA

#1,779 in Massachusetts

#29,944 in US

#56,228 in the World

Framingham, MA, United States of America

Solace Therapeutics, Inc.

Forward Citations = 571

20 inventors:

Kevin Gerald Connors (10 out of 37 patents)

Sheila K Wallin (5 out of 19 patents)

Hung H Cao (4 out of 20 patents)

4. John Gillespie, Jr (4 out of 12 patents)

5. William L Pintauro (4 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Solace Therapeutics, Inc.. Retrieved from https://idiyas.com/company/solace-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]